MEMP1972A, an anti-M1 prime monoclonal antibody, reduces serum IgE in healthy and allergic rhinitis subjects Source: Annual Congress 2012 - The best of pharmacology treatment for asthma and COPD Year: 2012
β2-adrenergic polymorphisms and serum total IgE levels in children with asthma Source: Annual Congress 2007 - Risk factors for childhood asthma: genetic and population studies Year: 2007
Age is a predictor of efficacy of monoclonal antibodies in allergic severe asthma Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses Year: 2019
The importance of quantifying serum antibody associated with allergic alveolitis Source: Eur Respir J 2004; 24: Suppl. 48, 355s Year: 2004
The association of serum IgG antibody with symptoms of hypersensitivity pneumonitis Source: Eur Respir J 2006; 28: Suppl. 50, 675s Year: 2006
The relationship between total IgE and specific antibody testing by Immunocap in screening allergic asthma Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD Year: 2020
Chlamydia pneumoniae (Cp)-specific IgE is associated with asthma severitySource: Annual Congress 2011 - New aspects in prevention and treatment of community-acquired pneumonia and lower respiratory tract infections Year: 2011
A monoclonal antibody to IL-1B attenuates the late asthmatic response to antigen challenge in patients with mild asthma Source: Annual Congress 2006 - Novel treatments for asthma Year: 2006
Epidemiology of serum IgE in children with allergic asthma Source: Eur Respir J 2001; 18: Suppl. 33, 373s Year: 2001
Total serum IgE variations in infants with bronchitis or asthma Source: Eur Respir J 2002; 20: Suppl. 38, 115s Year: 2002
Specific serum IgE is associated with seasonal symptom load in children with allergic rhinitis Source: Annual Congress 2008 - Risk factors for allergic asthma and allergic rhinitis Year: 2008
Determining early response to anti-IL5/IL5R monoclonal antibodies in severe eosinophilic asthma Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020
Omalizumab, a recombinant humanized monoclonal anti-IgE antibody, decreases the risk of serious asthma exacerbations requiring hospitalization in patients with moderate-to-severe allergic asthma Source: Eur Respir J 2001; 18: Suppl. 33, 37s Year: 2001
Monitoring free serum IgE in severe asthma patients treated with omalizumab Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011
Serum titres of cytokines show an imbalance in atopic asthma Source: Eur Respir J 2004; 24: Suppl. 48, 351s Year: 2004
Long-term asthma control with omalizumab, an anti-IgE monoclonal antibody, in patients with severe allergic asthma Source: Eur Respir J 2005; 26: Suppl. 49, 47s Year: 2005
Serum IgG and IgA antibodies to chramydia pneumoniae and severity of emphysema Source: Eur Respir J 2004; 24: Suppl. 48, 44s Year: 2004
Allergic asthma: total serum IgE age variations Source: Eur Respir J 2002; 20: Suppl. 38, 513s Year: 2002
Detection of IgG and IgE-abs to herpesviruses in asthmatic patients Source: Annual Congress 2009 - What is new in the regulation and monitoring of airway function? Year: 2009
Elevated serum ECP in wheezing infants predicts the development of atopic asthma Source: Eur Respir J 2002; 20: Suppl. 38, 192s Year: 2002